Objective
The purpose of this study was to gain a further understanding of the relationship between miR-152 and human leukocyte antigen (HLA)-G in human trophoblast cell line (JEG-3).
Study Design
The JEG-3 cells were transfected with pre–miR-152. The effect of the overexpressed miR-152 on HLA-G expression, trophoblast invasion, and natural killer (NK) cell–mediated cytolysis were assessed by reverse-transcription polymerase chain reaction (RT-PCR) and Western blot analysis, transwell invasion assay, and NK cell cytotoxicity assay, respectively.
Results
The miR-152 repressed HLA-G expression but exerted no effect on JEG-3 cell invasion, and overexpression of miR-152 led to increased NK cell–mediated cytolysis in JEG-3 cells.
Conclusion
The data indicate that miR-152 may function as an immune system enhancer through up-regulating NK cell–mediated cytolysis of host cells.
Human leukocyte antigen (HLA)-G is a nonclassical HLA class Ib molecule that is mainly expressed at the maternal-fetal interface during pregnancy as well as in tumors, infected tissues, transplanted organs, etc. Evidence shows that HLA-G is involved in inducing and maintaining immune tolerance via interaction with inhibitory receptors present on natural killer (NK) cells, T and B lymphocytes, and antigen-presenting cells.
HLA-G expression is necessary for a successful pregnancy. The abnormal expression of HLA-G may alter the maternal-fetal immune tolerance and thus be associated with failed pregnancy, such as preeclampsia and miscarriage. Moreover, HLA-G plays an important role in many human diseases, including cancer, viral infection, and inflammatory diseases as well as organ transplantation.
The fact that HLA-G exerts immunomodulatory effects during physiological and pathophysiological processes suggests that its expression is under tight regulation. An understanding of the regulation of HLA-G expression is essential to fully appreciate the function of this protein. However, the exact mechanisms underlying the regulation of HLA-G expression are still poorly understood. It has been reported previously that microRNAs (miRNAs) participate in the regulation of the HLA-G gene expression.
The miRNAs are noncoding ribonucleic acids (RNAs) of 21-24 nucleotides that function as negative regulators of gene expression by binding to complementary sequences in the 3′-untranslated region (3′-UTR) of their target gene messenger RNAs (mRNAs) and subsequent induction of translation inhibition, which can also be associated with transcript destabilization. The miRNAs play a fundamental role in diverse biological and pathological processes, which include cell proliferation, apoptosis, and carcinogenesis.
Recent data indicate that miR-152 targets HLA-G 3′-UTR in the human bronchial epithelial cell line. It is well known that the 2-8 nt (seed region) of miRNA is suggested to be the most important for target recognition. The HLA-G mRNA 3′-UTR of the human trophoblast cell line (JEG-3 choriocarcinoma cell line) contains a binding site that is reverse complementary with the miR-152 seed region ( Figure 1 ). Furthermore, previous work from our laboratory has demonstrated that miR-152 was overexpressed in preeclamptic placentas, in which low expression of HLA-G was confirmed.
These results of previous studies suggest that miR-152 may be involved in the pathogenesis of failed pregnancy through negatively regulation of HLA-G. To gain a further understanding of the relationship between miR-152 and HLA-G in the human trophoblast cells, we analyzed the effect of the overexpressed miR-152 on HLA-G expression, trophoblast invasion, and NK cell–mediated cytolysis in JEG-3 cells.
Materials and Methods
Cell lines and culture conditions
JEG-3 choriocarcinoma cells (HBT-36) and NK-92MI cells (CRL-2408) were obtained from American Type Culture Collection (Manassas, VA). The JEG-3 cells were cultured in Dulbecco’s modified Eagle medium (DMEM; Gibco, BRL, Gaithersburg, MD), containing 10% fetal bovine serum (FBS). The NK-92MI cells were maintained in alpha minimum essential medium (α-MEM, Gibco) supplemented with 2 mM L-glutamine, 0.2 mM i-inositol, 0.02 mM folic acid, 0.1 mM 2-mercaptoethanol, 12.5% FBS, and 12.5% horse serum. All cells were cultured at 37 o C in a humidified atmosphere of 5% CO 2 and 95% air.
Transient overexpression of hsa-miR-152
The miR-152 precursor (pre-miR-152) and Cy3 dye labeled pre-miR negative control #1 (pre-miR-control) were purchased from Ambion (Austin, TX). The JEG-3 cells were transfected with pre-miR-152 using siPORT NeoFx reagent (Ambion) according to the manufacturer’s protocol.
To confirm the efficiency of transfection, the Cy3-labeled control #1 was also transfected. The medium was replaced with fresh growth medium after 12 hours. Forty-eight to 72 hours after transfection, cells were used for reverse-transcription polymerase chain reaction (RT-PCR) analysis, Western blot analysis, transwell invasion assay, and NK cell cytotoxicity assay.
RT-PCR analysis
Total RNA was extracted with Trizol reagent (Invitrogen, Carlsbad, CA). RNA integrity was confirmed by electrophoresis in a 1.5% agarose denaturing gel. For the detection of HLA-G gene, 1 μg of the total RNA was subsequently reverse transcribed into complementary deoxyribonucleic acid (cDNA) primed by oligo (dT) with the use of the RevertAid first-strand cDNA synthesis kit (MBI; Fermentas, Vilnius, Lithuania). β-Actin was used as an endogenous control.
For the detection of mature miRNA, 4 μg of the total RNA was reverse transcribed to cDNA with gene-specific RT primer, which could fold to a stem-loop structure. The highly conserved and universally expressed small nuclear RNA U6 was used as an endogenous control. All primer sequences and the reaction conditions are shown in the Table . A 25 μL PCR master mix was prepared as follows: 1 μL RT products, 200 μmol/L deoxyribonucleoside triphosphates, 2 mmol/L MgCl 2 , 1 IU Taq polymerase, and 10 pmol of each primer.
Gene | Primer sequences (F: forward; R: reverse) | Annealing temperature (°C) | Cycle (n) |
---|---|---|---|
HLA-G | F: CTGACCCTGACCGAGACCT R: CTCGCTCTGGTTGTAGTAGCC | 56 | 29 |
β-Actin | F: TGCGCAGAAAACAAGATGAGATT R: TGGGGGACAAAAAGGGGGAAGG | 55 | 25 |
miR-152 | RT: GTCGTATCCAGTGCAGGGTCCGAG GTATTCGCACTGGATACGACcccaag F: GTCGTCAGTGCATGACAGAACTT R: GTGCAGGGTCCGAGGT | 60 | 35 |
U6 | R: AACGCTTCACGAATTTGCGT F: CTCGCTTCGGCAGCACA R: AACGCTTCACGAATTTGCGT | 60 | 30 |
HLA-G-UTR | F: GACTAGTAGAAAGAAGAGCTCAGATTGA R: CCCAAGCTTCAGAAGTAAGTTATAGCTCAG | 58 | 36 |
The amplification was ensured within the exponential phase of PCR by preliminary experiments. PCR products were subjected to electrophoresis on agarose gels. The relative densities of target genes normalized with control genes were analyzed with the Image-Pro Plus (software version 6.0; Media Cybernetics, Silver Spring, MD).
Western blot analysis
Infected cells were washed 3 times with ice-cold phosphate-buffered saline (PBS) and then lysed with 1× lysis buffer (Cell Signaling Technology, Beverly, MA). The supernatant was collected after centrifugation.
Protein estimation was carried out by the Bradford method. Thirty micrograms of protein per lane was separated by 12% sodium dodecyl sulfate–polyacry1-amide gel electrophoresis and then transferred onto a polyvinylidene fluoride membrane (Millipore, Bedford, MA) by semidry electroblotting. The membrane was blocked in 5% nonfat dry milk in PBST for 1 hour at room temperature and then incubated with monoclonal antibody MEM-G/1 (Serotec, Oxford, UK) in the PBS at 4°C overnight.
On the next day, the membrane was washed with PBST and incubated with horseradish peroxidase–conjugated goat antimouse immunoglobulin G (Sigma, St Louis, MO) for 1 hour at room temperature. Signals were detected with SuperSignal West Pico chemiluminescent substrate (Pierce, Rockford, IL). After stripping, the same membrane was reprobed with β-actin antibody (NeoMarkers, Fremont, CA) as internal loading control. The relative intensity of HLA-G was normalized to β-actin, which was determined by densitometric analysis.
Target in vitro assay
For the luciferase reporter experiment, the 3′-UTR segment of HLA-G (accession number NM_002127 ) was amplified by PCR. The cDNA transcribed from total RNA of JEG-3 cells was used as template. Primer sequences designed to carry the Spe I and Hind III sites are shown in the Table .
The PCR product was inserted into the Spe I and Hind III cloning sites of the pMIR-PEPORT luciferase expression reporter vector (Ambion) to generate pMIR-UTR. Transfection was performed with siPORT XP-1 reagent (Ambion). For the test group, transfections of JEG-3 cells were performed with pMIR-UTR and pre-miR-152.
For the blank control group, transfections were performed with pMIR-UTR but no pre-miR-152. For the negative control group, transfections were performed with pMIR-UTR and pre-miR-control. All cells were also transfected with pMIR-PEPORT β-galactosidase (pMIR-β-gal) for normalizing variability because of transfection differences. After 48 hours, the cells were lysed and measured for luciferase activity and β-gal activity with the use of the luciferase assay system and β-galactosidase enzyme assay system (Promega, Madison, WI) according to the manufacturer’s instructions.
Transwell invasion assay
In vitro cellular invasion was assayed by determining the ability of cells to invade a synthetic basement membrane. Briefly, infected cells were plated at 4 × 10 4 cells in transwell inserts (8-μm pore size; Costar, Cambridge, MA) precoated with type I collagen (Col I; 80 μg/mL; cell matrix type I A; Institute of Biochemistry, Osaka, Japan) and incubated with DMEM containing 0.2% FBS. Lower chambers were loaded with DMEM medium containing 10% FBS.
The cells were incubated at 37°C and allowed to invade through the collagen barrier for 24 hours. Following incubation, the invading cells were fixed with 4% paraformaldehyde and stained with hematoxylin, and noninvading cells were removed with a cotton swab. Cell invasion index was determined by counting the number of stained cells in 10 randomly selected nonoverlapping fields of the membranes with a light microscope. Images were captured with a Nikon microscope (TE2000S; Nikon, Tokyo, Japan; original magnification, ×200).
NK cell cytotoxicity assay
Cytotoxicity analysis was performed with CytoTox96 nonradioactive cytotoxicity assay (Promega) as the protocol instructed. Briefly, effector/target ratio (E/T) was optimized. The NK-92 cells (effector cells) were mixed with 1 × 10 5 JEG-3 cells (target cells) at different E/T ratios (ranging from 2.5:1 to 20:1). Target cell spontaneous release and maximal release of lactic dehydrogenase (LDH) and the effector cell spontaneous LDH release were determined by incubating these cells in medium alone. After incubation for 4 hours, the LDH measurement was performed by a standard 96-well plate reader. The following formula was used to compute percent cytotoxicity: percent cytotoxicity = (experimental – effector spontaneous – target spontaneous)/(target maximum – target spontaneous) × 100.
Statistical analysis
All values are presented as the mean ± SD of 3 individual experiments done in triplicate. Comparison of the values between groups was performed with 1-way analysis of variance by SPSS 11.0 software (SPSS Inc, Chicago, IL), and P < .05 was taken to be statistically significant.